tamibarotene has been researched along with Acute Lymphoid Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, S; Jimi, S; Matsumoto, T; Suzumiya, J; Takamatsu, Y; Tamura, K | 1 |
1 other study(ies) available for tamibarotene and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Am80 inhibits stromal cell-derived factor-1-induced chemotaxis in T-cell acute lymphoblastic leukemia cells.
Topics: Benzoates; Cell Membrane; Cell Movement; Chemokine CXCL12; Chemotaxis; Flow Cytometry; Gene Expression Regulation, Leukemic; Humans; Jurkat Cells; K562 Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase C; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocytes; Tetrahydronaphthalenes | 2010 |